Review
How should P2x purinoceptors be classified pharmacologically?

https://doi.org/10.1016/S0165-6147(00)89010-0Get rights and content

Abstract

When ATP is released as a neurotransmitter from central and peripheral nerves it acts at P2x purinoceptors to produce postsynaptic depolarization and excitation. The P2x purinoceptor was originally classified on the basis of the relative agonist potencies of ATP and a number of its structural analogues. However, it is now clear that the potency of some agonists is greatly decreased by breakdown by ectonucleotidase enzymes, leading to an incorrect determination of agonist potency order. In this article, Charles Kennedy and Paul Leff discuss recent results that indicate that the established classification of P2x purinoceptors is no longer valid and needs redefinition.

References (47)

  • G. Burnstock et al.

    Gen. Pharmacol.

    (1985)
  • S.E. O'Connor et al.

    Trends Pharmacol. Sci.

    (1991)
  • M.P. Abbracchio et al.

    Pharmacol. Ther.

    (1994)
  • T.E. Webb

    FEBS Lett.

    (1993)
  • L.A. Welford et al.

    Eur. J. Pharmacol.

    (1986)
  • L.A. Welford et al.

    Eur. J. Pharmacol.

    (1987)
  • E.L. Gordon et al.

    J. Biol. Chem.

    (1989)
  • J.L. Boyer et al.

    J. Biol. Chem.

    (1989)
  • J. Chapal et al.

    Eur. J. Pharmacol.

    (1983)
  • C. Kennedy et al.

    Eur. J. Pharmacol.

    (1985)
  • J.L. Gordon

    Biochem. J.

    (1986)
  • B.B. Fredholm

    Pharmacol. Rev.

    (1994)
  • K.D. Lustig et al.
  • S. Valera

    Nature

    (1994)
  • A.J. Brake et al.

    Nature

    (1994)
  • C. Kennedy

    Arch. Int. Pharmacodyn.

    (1990)
  • S.E. O'Connor et al.

    Br. J. Pharmacol.

    (1990)
  • R.J. Evans et al.

    Br. J. Pharmacol.

    (1994)
  • R. Inoue et al.

    Br. J. Pharmacol.

    (1990)
  • A.U. Ziganshin et al.

    Drug Dev. Res.

    (1994)
  • B.E. Crack

    Br. J. Pharmacol.

    (1995)
  • McKechnie, K. C. W., Crack, B. E., Dainty, I. A. and Leff, P. Br. J. Pharmacol. (in...
  • B.E. Crack et al.

    Br. J. Pharmacol.

    (1994)
  • Cited by (166)

    • ATP as a cotransmitter in the autonomic nervous system

      2015, Autonomic Neuroscience: Basic and Clinical
      Citation Excerpt :

      The neurotransmitter actions of NA are terminated by uptake back into sympathetic nerves via a well-characterised transporter. In contrast, ATP is rapidly broken down in the synapse (Evans and Kennedy, 1994; Kennedy and Leff, 1995) and the majority of ATP released is detected as adenosine (Todorov et al., 1996). Four extracellular, membrane-bound ecto-nucleoside triphosphate diphosphohydrolases (NTPDase1, 2, 3 and 8), two ecto-nucleotide pyrophosphatases/phosphodiesterases (NPP1 and 3) and an ecto-5′-nucleotidase have been identified, which dephosphorylate ATP to ADP, AMP and adenosine (Robson et al., 2006).

    • Alpha, beta methylene ATP

      2007, xPharm: The Comprehensive Pharmacology Reference
    • 2-MeSATP

      2007, xPharm: The Comprehensive Pharmacology Reference
    • Human airway ecto-adenylate kinase: A mechanism to propagate ATP signaling on airway surfaces

      2003, Journal of Biological Chemistry
      Citation Excerpt :

      P2XRs may desensitize rapidly, i.e. within ∼30 s (16, 20), suggesting that a prolonged ATP level may not be important for signaling. On the other hand, P2YRs are activated by lower ATP concentrations (EC50 = 0.1–1 μm; for a review, see Ref. 21) and desensitize less rapidly. For instance, Cl− currents (61) and CBF (19) induced by 100 μm ATP on airway epithelial surfaces remained above 60% of maximal response for at least 15 min.

    • Extracellular ATP is an autocrine/paracrine regulator of hypoxia-induced adventitial fibroblast growth: Signaling through extracellular signal-regulated kinase-1/2 and the Egr-1 transcription factor

      2002, Journal of Biological Chemistry
      Citation Excerpt :

      A similar shift in the concentration-dependent curve was also observed in the presence of ATP-regenerating system (Fig. 3 B). Because the concentration range of ATP found to stimulate DNA synthesis could activate both P2Y and P2X receptors (11, 34, 35), we evaluated the effects of selective P2Y and P2X receptor agonists on DNA synthesis. We found that the P2Y receptor agonists UTP, ADPβS, and the P2Y/P2X agonist MeSATP stimulated increases in thymidine incorporation which were nearly equivalent to those observed with ATP at doses causing a maximal effect (Fig. 3C).

    View all citing articles on Scopus
    View full text